| More

Cord blood banks: Current challenges and vision

Views: 128 Downloads: 117
Χριστίνα Δάφνη (Christina Dafni), Νικόλαος Πεφάνης (Nikolaos Pefanis), Δανάη Δήμου (Danai Dimou), Γεώργιος Πούλος (Georgios Poulos), Άννα Μαρία Ιωαννίδου (Anna Maria Ioannidou), Θεοδώρα Κατσίλα (Theodora Katsila), Γεώργιος Πατρινός (Giorgos Patrinos)
Χριστίνα Δάφνη (Christina Dafni), Νικόλαος Πεφάνης (Nikolaos Pefanis), Δανάη Δήμου (Danai Dimou), Γεώργιος Πούλος (Georgios Poulos), Άννα Μαρία Ιωαννίδου (Anna Maria Ioannidou), Θεοδώρα Κατσίλα (Theodora Katsila), Γεώργιος Πατρινός (Giorgos Patrinos)

Abstract


Stem cell transplants have been proved beneficial toward optimum disease management. In particular, cord blood has been a valuable source of stem cells with clinically proven applications for the treatment of a series of heamatological and immune system malignancies and several genetic disorders.
To this end, cord blood banking has been established in the public and private sector. Nevertheless, current morals and ethics as well as the lack of a well-defined legal framework for the operation of cord blood banks hamper their clinical role and concern the general public.


Keywords


Stem cell transplants; cord blood banks; cord blood

References


Takahashi K and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. cell, 2006. 126(4): 663-676.

Pozzobon M, Piccoli M, De Coppi P. Stem cells from fetal membranes and amniotic fluid: markers for cell isolation and therapy. Cell and tissue banking, 2014. 15(2): 199-211.

Walters L. Human embryonic stem cell research: an intercultural perspective. Kennedy Institute of Ethics Journal, 2004. 14(1): 3-38.

Ji EH, et al. Viability of pulp stromal cells in cryopreserved deciduous teeth. Cell and tissue banking, 2014. 15(1): 67-74.

Ruggeri A. Alternative donors: cord blood for adults. in Seminars in hematology. 2016. Elsevier.

Armson BA, Allan DS, Casper RF. Umbilical Cord Blood: Counselling, Collection, and Banking. Journal of Obstetrics and Gynaecology Canada, 2015. 37(9): 832-844.

Foeken, L., et al., Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone marrow transplantation, 2010. 45(5): 811-818.

Hurlbut JB. Promising waste: biobanking, embryo research, and infrastructures of ethical efficiency. Monash bioethics review, 2015. 33(4): 301-324.

Samuel GN, Kerridge IH, O Brien TA. Umbilical cord blood banking: public good or private benefit? Medical Journal of Australia, 2008. 188(9): 533.

Kahn JP and Mastroianni AC. Creating a stem cell donor: a case study in reproductive genetics. Kennedy Institute of Ethics Journal, 2004. 14(1): 81-96.

Green RM. Benefiting from ‘evil’: an incipient moral problem in human stem cell research. Bioethics, 2002. 16(6): 544-556.

Rocha V, et al. Pediatric related and unrelated cord blood transplantation for malignant diseases. Bone marrow transplantation, 2009. 44(10): 653-659.

Merviel P, et al. The bioethics law revision: comparative analysis of contributions from different public and professional offices. Assisted Reproductive Technology, embryo and stem cells research, umbilical cord blood bank. Gynecologie, obstetrique & fertilite, 2009. 37(9): 733-741.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Bioethica